BBIO
BBIO
NASDAQ · Biotechnology

Bridgebio Pharma Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$65.88
-3.35 (-4.84%)
As of Sep 23, 7:25 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 26 90%
Hold 3 10%
Sell 0 0%
Price Target
Analyst Price Target +188.5% upside
Low Target $141.92
Average Target $190.06
High Target $243.96
Current Price $65.88
Current
$65.88
Target
$190.06
$141.92 $190.06 avg $243.96
Scenario Analysis
Bear Case
$141.92
115.4%
Low target
Base Case
$190.06
+188.5%
Avg target
Bull Case
$243.96
+270.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$93.42
-29.5% from high
52-Week Low
$48.78
+35.1% from low
50-Day SMA
$75.38
-12.6% vs SMA
200-Day SMA
$56.39
+16.8% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$190.06
+103.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +141.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.8%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.3%